Note that some links may require registration or subscription.

Former President Bill Clinton was admitted to MedStar Georgetown University Hospital in Washington, D.C. on Monday with a fever, according to his spokesperson. (The Hill)

Could this generic approval lead to lower cost semaglutide (Ozempic, Wegovy)? (USA Today)

For patients wanting to pause their GLP-1 drugs for diabetes or weight loss this holiday season, here's what doctors say they should know. (CNN)

President Joe Biden signed the annual defense authorization bill into law, despite objections to language banning transgender care for military children. (AP)

A federal judge in Texas ruled that the Biden administration likely exceeded its authority in a rule bolstering privacy protections for women seeking abortions and patients receiving gender transition treatments. (Reuters via MSN)

After gender-affirming care had disappeared in the U.S. for decades, trans patients and advocates are fighting to maintain access to life-changing surgeries. (STAT)

The FDA issued an alert regarding endoscope accessories -- the MAJ-891 forceps/irrigation plug from Olympus -- following reports of 120 injuries and one death due to infection.

And Alcon Laboratories issued a voluntary nationwide recall of certain Systane Lubricant Eye Drops due to fungal contamination, according to a company announcement posted by the FDA.

Bristol Myers Squibb announced positive topline results from two pivotal phase III trials evaluating the efficacy and safety of deucravacitinib (Sotyktu) in adults with active psoriatic arthritis.

The FDA approved vibegron (Gemtesa) to treat men with overactive bladder symptoms who are receiving pharmacological therapy for benign prostatic hyperplasia, Sumitomo Pharma said.

Sequana Medical received approval from the agency to market its alfapump device to treat recurrent or refractory ascites due to liver cirrhosis, the company announced.